Rapid assessment of fetal hemoglobin concentration with the HemoCue system.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 1699183.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Successful treatment of severe fetal hemolytic disease depends on rapid and accurate measurement of fetal hemoglobin or hematocrit. The HemoCue is a portable hemoglobinometer that rapidly measures hemoglobin concentration. To evaluate the potential role of this instrument in fetal transfusion therapy, we measured hemoglobin concentration with the HemoCue and compared it with Coulter counter determination of hemoglobin in 39 fetuses. The HemoCue accurately measured fetal hemoglobin concentration (y = -0.3986 + 1.0276x; r = 0.97, P less than .001). This instrument is valuable for use with intravascular fetal transfusions.
Medical subject headings
- Blood Transfusion, Intrauterine
- Fetal Hemoglobin
- Hemoglobinometry